Patient Pathfinder: Clinical Trials

Clinical Trial Finder Myeloproliferative Neoplasms Trials

Clinical Trials for Myeloproliferative Neoplasms

Every life-saving or life-extending treatment thatâ€™s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.

Clinical trials also give patients a chance to try a treatment before itâ€™s approved by the U.S. Food and Drug Administration.

See Locations Near You

What are Myeloproliferative Neoplasms (MPNs)?

There are 127 active Myeloproliferative Neoplasms trials

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Study Type: Interventional Phase 1

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

Study Type: Interventional Phase 2

Asciminib Roll-over Study

Study Type: Interventional Phase 4

Study to Assess SLN124 in Patients With Polycythemia Vera

Study Type: Interventional Phase 1

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

Study Type: Interventional Phase 2

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Study Type: Interventional Phase 3

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

Study Type: Interventional Phase 2

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Study Type: Interventional Phase 1

« Previous 1 2 3 4 5 6 … 16 Next »

There are 127 active Myeloproliferative Neoplasms trials

Filter Results

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.